Aileron Therapeutics Inc’s (NASDAQ: ALRN) Stock Rises 17.65 Percent, But Further Upside Could Be On The Way
Aileron Therapeutics Inc (NASDAQ:ALRN)’s traded shares stood at 1.75 million during the last session, with the company’s beta value hitting 2.33. At the close of